The role of caspase activity in the viral response of pegylated interferon alfa-2B plus ribavirin therapy

被引：0
|
作者：
Oze, Tsugiko
Hiramatsu, Naoki
Kanto, Tatsuya
Kurashige, Nao
Yakushijin, Takayuki
Uyama, Hirokazu
Igura, Takumi
Oshita, Masahide
Katayama, Kazuhiro
Yoshihara, Harumasa
Imai, Yasuharu
Kato, Michio
Takehara, Tetsuo
Kasahara, Akinori
Tamura, Shinji
Hayashi, Norio
机构：
[1] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan
[2] Osaka Police Hosp, Osaka, Japan
[3] Osaka Kouseinenkin Hosp, Osaka, Japan
[4] Osaka Rousai Hosp, Sakai, Osaka, Japan
[5] Ikeda City Hosp, Ikeda, Osaka, Japan
[6] Osaka Natl Hosp, Natl Hosp Org, Osaka, Japan
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
333
引用
收藏
页码：313A / 314A
页数：2
相关论文
共 50 条
  • [21] Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2
    Taura, Naota
    Ichikawa, Tatsuki
    Miyaaki, Hisamitsu
    Kadokawa, Yoshiko
    Tsutsumi, Takuya
    Tsuruta, Shotaro
    Kato, Yuji
    Inoue, Osami
    Kinoshita, Noboru
    Ohba, Kazuo
    Kato, Hiroyuki
    Ohata, Kazuyuki
    Masuda, Junichi
    Hamasaki, Keisuke
    Yatsuhashi, Hiroshi
    Nakao, Kazuhiko
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2012, 2012
  • [22] Distinct hepatitis C virus kinetics in HIV plus patients treated with ribavirin plus either pegylated interferon alfa-2a or alfa-2b
    Vispo, E.
    Barreiro, P.
    Rodriguez-Novoa, S.
    Morello, J.
    Labarga, P.
    Martin-Carbonero, L.
    Maida, I.
    Garcia-Gasco, P.
    Soriano, V.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S314 - S314
  • [23] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Rovner, D
    Brass, C
    GASTROENTEROLOGY, 2002, 122 (04) : A626 - A626
  • [24] Cost-utility-analysis of peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin as initial therapy for Chinese naive patients with chronic hepatitis C
    Tarn, YH
    Lin, WA
    VALUE IN HEALTH, 2006, 9 (03) : A46 - A46
  • [25] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Pizov, O
    Brass, C
    GASTROENTEROLOGY, 2001, 120 (05) : A383 - A383
  • [26] Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium
    Wong, JB
    Nevens, F
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (02): : 110 - 111
  • [27] SUPPRESSIVE EFFECT OF PEGYLATED INTERFERON ALFA-2B PLUS RIBAVIRIN COMBINATION THERAPY ON INCIDENCE OF HEPATOCELLLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C
    Oze, Tsugiko
    Hiramatsu, Naoki
    Yakushijin, Takayuki
    Mochizuki, Kiyoshi
    Oshita, Masahide
    Hagiwara, Hideki
    Mita, Eiji
    Fukui, Hiroyuki
    Inui, Yoshiaki
    Hijioka, Taizo
    Inada, Masami
    Tamura, Shinji
    Yoshihara, Harumasa
    Inoue, Atsuo
    Imai, Yasuharu
    Kato, Michio
    Hosui, Atsushi
    Miyagi, Takuya
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Kiso, Shinichi
    Kanto, Tatsuya
    Kasahara, Akinori
    Takehara, Tetsuo
    Hayashi, Norio
    HEPATOLOGY, 2010, 52 (04) : 769A - 769A
  • [28] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 : 1961 - 1966
  • [29] IMPROVEMENT OF ADIPOKINES IN HCV ERADICATED PATIENT TREATED WITH PEGYLATED INTERFERON ALFA-2B AND RIBAVIRIN
    Kaneko, Fumihiko
    Yokomori, Hiroaki
    Kumagai, Naoki
    Toda, Kyoko
    Tsunematsu, Satoshi
    Wakabayashi, Kanji
    Tsuchimoto, Kanji
    Saito, Hidetsugu
    Hibi, Toshifumi
    HEPATOLOGY, 2010, 52 (04) : 808A - 808A
  • [30] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 (7) : 2009 - 2009
12345